View more in
Cancer

Surgical Resectability in Stage IIIA-N2 NSCLC

onclive.com
 2021-06-03

Cover picture for the articleChristian Grohé, MD, and Gary Doherty, MRCP, PhD, consider factors that may influence the resectability of patients with stage IIIA-N2 disease, such as biomarker status, performance status, and imaging results. Neal Navani, MRCP, MSc, PhD: I think we would all appreciate that there has been huge innovation in the treatment...

www.onclive.com

Comments / 0

Comments / 0